Earnings History Data for Spyre Therapeutics, Inc. (SYRE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Spyre Therapeutics, Inc.

Spyre Therapeutics is a biotechnology company which aims to create inflammatory bowel disease products by combining antibody engineering, rational therapeutic combinations and precision medicine approaches for patient selection. Spyre Therapeutics, formerly known as Aeglea BioTherapeutics Inc., is based in WALTHAM, Mass.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-11-2024 PM SYRE Spyre Therapeutics, Inc. 1,829 -1.36 -0.80 0.00 Spyre Therapeutics GAAP EPS of -$1.36
[11/8/2024 12:27 AM]
39.50 1.81 
(4.80%)
37.69 0.0 
(0.00%)
8.43 - 47.97 363,458 400,000 20,877
07-08-2024 AH SYRE Spyre Therapeutics, Inc. 1,047 -0.86 -0.90 0.00 Spyre Therapeutics GAAP EPS of -$0.86 beats by $0.16
[8/7/2024 6:17 PM]
25.16 0.61 
(2.46%)
24.55 0.0 
(0.00%)
8.43 - 47.97 520,512 410,000 6,624
29-02-2024 AH SYRE Spyre Therapeutics, Inc. 101.00 -2.28 -0.48 0.00 Spyre Therapeutics GAAP EPS of -$4.05
[2/29/2024 5:58 PM]
29.84 2.40 
(8.76%)
28.32 0.88 
(3.21%)
2.66 - 32.99 964,599 600,000 565